Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000905718-22-000551
Filing Date
2022-04-07
Accepted
2022-04-07 16:39:32
Documents
1
Group Members
ABINGWORTH BIOVENTURES 8, LP

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.1 veratherap_sc13da1mar282022.htm SC 13D/A 42075
  Complete submission text file 0000905718-22-000551.txt   43565
Mailing Address 38 JERMYN STREET LONDON X0 SW1Y 6DN
Business Address 38 JERMYN STREET LONDON X0 SW1Y 6DN 44 (0)20 7534 1500
Abingworth LLP (Filed by) CIK: 0001397144 (see all company filings)

EIN.: 980518585 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: SC 13D/A

Mailing Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005
Business Address 8000 MARINA BOULEVARD, SUITE 120 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Subject) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92556 | Film No.: 22814348
SIC: 2834 Pharmaceutical Preparations